§ 5-19.3-5. Prohibition on certain discriminatory actions by a pharmaceutical manufacturer, agent, or affiliate of such manufacturer related to 340B entities.
(a) A pharmaceutical manufacturer, agent, or affiliate of such manufacturer shall not deny, restrict, prohibit, or otherwise interfere with, either directly or indirectly, the acquisition of a 340B drug by, or delivery of a 340B drug to, a pharmacy that is under contract with a 340B covered entity and is authorized under such contract to receive and dispense 340B drugs on behalf of the covered entity unless such receipt is prohibited by the United States department of health and human services.
(b) A pharmaceutical manufacturer, agent, or affiliate of such manufacturer shall not interfere with a 340B contract pharmacy that is actively contracted with a 340B covered entity.
(c) A pharmaceutical manufacturer, agent, or affiliate of such manufacturer shall not impose additional terms or limitations not required by federal law as a condition of 340B participation.
History of Section.
P.L. 2025, ch. 288, § 1, effective October 1, 2025; P.L. 2025, ch. 290, § 1, effective
October 1, 2025.